544 related articles for article (PubMed ID: 10928172)
1. Infrequent alternations of RB pathway (Rb-p16INK4A-cyclinD1) in adenoid cystic carcinoma of salivary glands.
Shintani S; Mihara M; Nakahara Y; Kiyota A; Yoshihama Y; Ueyama Y; Matsumura T
Anticancer Res; 2000; 20(3B):2169-75. PubMed ID: 10928172
[TBL] [Abstract][Full Text] [Related]
2. Abnormal expression of Rb pathway-related proteins in salivary gland acinic cell carcinoma.
Liu T; Zhu E; Wang L; Okada T; Yamaguchi A; Okada N
Hum Pathol; 2005 Sep; 36(9):962-70. PubMed ID: 16153458
[TBL] [Abstract][Full Text] [Related]
3. The P16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung.
Beasley MB; Lantuejoul S; Abbondanzo S; Chu WS; Hasleton PS; Travis WD; Brambilla E
Hum Pathol; 2003 Feb; 34(2):136-42. PubMed ID: 12612881
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of cyclin D1 and cortactin is primarily independent of gene amplification in salivary gland adenoid cystic carcinoma.
Greer RO; Said S; Shroyer KR; Marileila VG; Weed SA
Oral Oncol; 2007 Sep; 43(8):735-41. PubMed ID: 17113340
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of cyclins D1 and E is frequent in bronchial preneoplasia and precedes squamous cell carcinoma development.
Lonardo F; Rusch V; Langenfeld J; Dmitrovsky E; Klimstra DS
Cancer Res; 1999 May; 59(10):2470-6. PubMed ID: 10344760
[TBL] [Abstract][Full Text] [Related]
6. Alterations of expression of Rb, p16(INK4A) and cyclin D1 in non-small cell lung carcinoma and their clinical significance.
Brambilla E; Moro D; Gazzeri S; Brambilla C
J Pathol; 1999 Aug; 188(4):351-60. PubMed ID: 10440744
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of galectin-3, beta-catenin, and cyclin D1 in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of salivary glands.
Ferrazzo KL; Neto MM; dos Santos E; dos Santos Pinto D; de Sousa SO
J Oral Pathol Med; 2009 Oct; 38(9):701-7. PubMed ID: 19659475
[TBL] [Abstract][Full Text] [Related]
8. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC
Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942
[TBL] [Abstract][Full Text] [Related]
9. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.
Dreyling MH; Bullinger L; Ott G; Stilgenbauer S; Müller-Hermelink HK; Bentz M; Hiddemann W; Döhner H
Cancer Res; 1997 Oct; 57(20):4608-14. PubMed ID: 9377576
[TBL] [Abstract][Full Text] [Related]
10. Alterations in the p16INK4a/cyclin D1/RB pathway in gastrointestinal tract endocrine tumors.
Li AF; Li AC; Tsay SH; Li WY; Liang WY; Chen JY
Am J Clin Pathol; 2008 Oct; 130(4):535-42. PubMed ID: 18794045
[TBL] [Abstract][Full Text] [Related]
11. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines.
Sartor M; Steingrimsdottir H; Elamin F; Gäken J; Warnakulasuriya S; Partridge M; Thakker N; Johnson NW; Tavassoli M
Br J Cancer; 1999 Apr; 80(1-2):79-86. PubMed ID: 10389982
[TBL] [Abstract][Full Text] [Related]
12. Alterations of Rb pathway (Rb-p16INK4-cyclin D1) in preinvasive bronchial lesions.
Brambilla E; Gazzeri S; Moro D; Lantuejoul S; Veyrenc S; Brambilla C
Clin Cancer Res; 1999 Feb; 5(2):243-50. PubMed ID: 10037171
[TBL] [Abstract][Full Text] [Related]
13. Expression and clinical significance of the G1-S modulators in carcinoma of the extrahepatic bile duct.
Ito Y; Takeda T; Sakon M; Monden M; Tsujimoto M; Matsuura N
Anticancer Res; 2000; 20(1A):337-44. PubMed ID: 10769677
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of key cell cycle genes (p16/cyclin D1/pRb) in head and neck squamous carcinomas.
Lai S; El-Naggar AK
Lab Invest; 1999 Mar; 79(3):255-60. PubMed ID: 10092061
[TBL] [Abstract][Full Text] [Related]
15. Altered p16/MTS1/CDKN2 and cyclin D1/PRAD-1 gene expression is associated with the prognosis of squamous cell carcinoma of the esophagus.
Takeuchi H; Ozawa S; Ando N; Shih CH; Koyanagi K; Ueda M; Kitajima M
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2229-36. PubMed ID: 9815619
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression.
Geradts J; Kratzke RA; Niehans GA; Lincoln CE
Cancer Res; 1995 Dec; 55(24):6006-11. PubMed ID: 8521382
[TBL] [Abstract][Full Text] [Related]
17. [The expression of P16, Rb and cyclin D1 and biological behavior of laryngeal cancer].
Dai S; Huang W; Gan X
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1997 Oct; 32(5):299-301. PubMed ID: 10743098
[TBL] [Abstract][Full Text] [Related]
18. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma.
Okami K; Reed AL; Cairns P; Koch WM; Westra WH; Wehage S; Jen J; Sidransky D
Oncogene; 1999 Jun; 18(23):3541-5. PubMed ID: 10376532
[TBL] [Abstract][Full Text] [Related]
19. Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity.
Jares P; Campo E; Pinyol M; Bosch F; Miquel R; Fernandez PL; Sanchez-Beato M; Soler F; Perez-Losada A; Nayach I; Mallofré C; Piris MA; Montserrat E; Cardesa A
Am J Pathol; 1996 May; 148(5):1591-600. PubMed ID: 8623927
[TBL] [Abstract][Full Text] [Related]
20. Cell cycle-related gene abnormalities and product expression in esophageal carcinoma.
Roncalli M; Bosari S; Marchetti A; Buttitta F; Bossi P; Graziani D; Peracchia A; Bonavina L; Viale G; Coggi G
Lab Invest; 1998 Sep; 78(9):1049-57. PubMed ID: 9759649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
